CD19 CAR T cells: Clinical Trials

4 trials of CD19 CAR T cells, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 not yet recruiting, 1 unknown. 3 Phase 1, 1 Early Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Unknown 1
Early Phase 11Not yet recruiting 1
Phase 21Unknown 1

Follow CD19 CAR T cells: new trials by email Literature Review of CD19 CAR T cells trials Research Report on CD19 CAR T cells

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Autologous Bedside CD19 CAR T-cell Therapy for B-ALL
CD19 CAR T cells - B-Cell Acute Lymphoblastic Leukemia, Adult
Early Phase 1Not yet recruitingThe General Hospital of Western Theater Command502025-12-012025-12-11
CD19 CAR T Cells in Patients With Relapsed or Refractory CD19 Positive B-cell Lymphoma
CD19 CAR T cells - Lymphomas Non-Hodgkin's B-Cell, Relapse
Phase 1CompletedInstitute of Hematology & Blood Diseases Hospital, China202017-06-082026-02-11
CD19 CAR T Cells in Patients With Resistant or Refractory CD19+ Acute Lymphoblastic Leukemia
CD19 CAR T cells - Acute Lymphoblastic Leukemia, Adult B-Cell, Acute Lymphoblastic Leukaemia Recurrent
Phase 1CompletedInstitute of Hematology & Blood Diseases Hospital, China202016-11-012025-06-03
T-cells Expressing Anti-CD19 CAR in Pediatric and Young Adults With B-cell Malignancies
CD19 CAR T cells - Acute Lymphoblastic Leukemia, B-precursor, Non-Hodgkin Lymphoma, B-cell
Phase 1 / Phase 2UnknownSheba Medical Center3002016-11-012020-11-03

Conditions studied

Precursor Cell Lymphoblastic Leukemia-Lymphoma (2)  ·  Burkitt Lymphoma (1)  ·  Leukemia (1)  ·  Lymphoma (1)  ·  Lymphoma, B-Cell (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Recurrence (1)

Sponsors

Institute of Hematology & Blood Diseases Hospital, China (2)  ·  Sheba Medical Center (1)  ·  The General Hospital of Western Theater Command (1)

Countries

China (3)  ·  Israel (1)

Top investigators

Dehui Zou, Dr. (1)  ·  Hai Yi, M.D. & Ph.D. (1)  ·  Jianxiang Wang, Dr. (1)

Results publications

PMID 30187944, PMID 32894185, PMID 33990415, PMID 34515338, PMID 40269280, PMID 40960310, PMID 41429239